Cargando…

Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling

Human cardiomyocytes (CMs) have potential for use in therapeutic cell therapy and high-throughput drug screening. Because of the inability to expand adult CMs, their large-scale production from human pluripotent stem cells (hPSC) has been suggested. Significant improvements have been made in underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Bianca, Löbel, Wiebke, Finklea, Ferdous, Halloin, Caroline, Ritzenhoff, Katharina, Manstein, Felix, Mohammadi, Samira, Hashemi, Mohammadjafar, Zweigerdt, Robert, Lipke, Elizabeth, Cremaschi, Selen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390976/
https://www.ncbi.nlm.nih.gov/pubmed/32793579
http://dx.doi.org/10.3389/fbioe.2020.00851
_version_ 1783564554942283776
author Williams, Bianca
Löbel, Wiebke
Finklea, Ferdous
Halloin, Caroline
Ritzenhoff, Katharina
Manstein, Felix
Mohammadi, Samira
Hashemi, Mohammadjafar
Zweigerdt, Robert
Lipke, Elizabeth
Cremaschi, Selen
author_facet Williams, Bianca
Löbel, Wiebke
Finklea, Ferdous
Halloin, Caroline
Ritzenhoff, Katharina
Manstein, Felix
Mohammadi, Samira
Hashemi, Mohammadjafar
Zweigerdt, Robert
Lipke, Elizabeth
Cremaschi, Selen
author_sort Williams, Bianca
collection PubMed
description Human cardiomyocytes (CMs) have potential for use in therapeutic cell therapy and high-throughput drug screening. Because of the inability to expand adult CMs, their large-scale production from human pluripotent stem cells (hPSC) has been suggested. Significant improvements have been made in understanding directed differentiation processes of CMs from hPSCs and their suspension culture-based production at chemically defined conditions. However, optimization experiments are costly, time-consuming, and highly variable, leading to challenges in developing reliable and consistent protocols for the generation of large CM numbers at high purity. This study examined the ability of data-driven modeling with machine learning for identifying key experimental conditions and predicting final CM content using data collected during hPSC-cardiac differentiation in advanced stirred tank bioreactors (STBRs). Through feature selection, we identified process conditions, features, and patterns that are the most influential on and predictive of the CM content at the process endpoint, on differentiation day 10 (dd10). Process-related features were extracted from experimental data collected from 58 differentiation experiments by feature engineering. These features included data continuously collected online by the bioreactor system, such as dissolved oxygen concentration and pH patterns, as well as offline determined data, including the cell density, cell aggregate size, and nutrient concentrations. The selected features were used as inputs to construct models to classify the resulting CM content as being “sufficient” or “insufficient” regarding pre-defined thresholds. The models built using random forests and Gaussian process modeling predicted insufficient CM content for a differentiation process with 90% accuracy and precision on dd7 of the protocol and with 85% accuracy and 82% precision at a substantially earlier stage: dd5. These models provide insight into potential key factors affecting hPSC cardiac differentiation to aid in selecting future experimental conditions and can predict the final CM content at earlier process timepoints, providing cost and time savings. This study suggests that data-driven models and machine learning techniques can be employed using existing data for understanding and improving production of a specific cell type, which is potentially applicable to other lineages and critical for realization of their therapeutic applications.
format Online
Article
Text
id pubmed-7390976
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73909762020-08-12 Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling Williams, Bianca Löbel, Wiebke Finklea, Ferdous Halloin, Caroline Ritzenhoff, Katharina Manstein, Felix Mohammadi, Samira Hashemi, Mohammadjafar Zweigerdt, Robert Lipke, Elizabeth Cremaschi, Selen Front Bioeng Biotechnol Bioengineering and Biotechnology Human cardiomyocytes (CMs) have potential for use in therapeutic cell therapy and high-throughput drug screening. Because of the inability to expand adult CMs, their large-scale production from human pluripotent stem cells (hPSC) has been suggested. Significant improvements have been made in understanding directed differentiation processes of CMs from hPSCs and their suspension culture-based production at chemically defined conditions. However, optimization experiments are costly, time-consuming, and highly variable, leading to challenges in developing reliable and consistent protocols for the generation of large CM numbers at high purity. This study examined the ability of data-driven modeling with machine learning for identifying key experimental conditions and predicting final CM content using data collected during hPSC-cardiac differentiation in advanced stirred tank bioreactors (STBRs). Through feature selection, we identified process conditions, features, and patterns that are the most influential on and predictive of the CM content at the process endpoint, on differentiation day 10 (dd10). Process-related features were extracted from experimental data collected from 58 differentiation experiments by feature engineering. These features included data continuously collected online by the bioreactor system, such as dissolved oxygen concentration and pH patterns, as well as offline determined data, including the cell density, cell aggregate size, and nutrient concentrations. The selected features were used as inputs to construct models to classify the resulting CM content as being “sufficient” or “insufficient” regarding pre-defined thresholds. The models built using random forests and Gaussian process modeling predicted insufficient CM content for a differentiation process with 90% accuracy and precision on dd7 of the protocol and with 85% accuracy and 82% precision at a substantially earlier stage: dd5. These models provide insight into potential key factors affecting hPSC cardiac differentiation to aid in selecting future experimental conditions and can predict the final CM content at earlier process timepoints, providing cost and time savings. This study suggests that data-driven models and machine learning techniques can be employed using existing data for understanding and improving production of a specific cell type, which is potentially applicable to other lineages and critical for realization of their therapeutic applications. Frontiers Media S.A. 2020-07-23 /pmc/articles/PMC7390976/ /pubmed/32793579 http://dx.doi.org/10.3389/fbioe.2020.00851 Text en Copyright © 2020 Williams, Löbel, Finklea, Halloin, Ritzenhoff, Manstein, Mohammadi, Hashemi, Zweigerdt, Lipke and Cremaschi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Williams, Bianca
Löbel, Wiebke
Finklea, Ferdous
Halloin, Caroline
Ritzenhoff, Katharina
Manstein, Felix
Mohammadi, Samira
Hashemi, Mohammadjafar
Zweigerdt, Robert
Lipke, Elizabeth
Cremaschi, Selen
Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling
title Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling
title_full Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling
title_fullStr Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling
title_full_unstemmed Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling
title_short Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling
title_sort prediction of human induced pluripotent stem cell cardiac differentiation outcome by multifactorial process modeling
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390976/
https://www.ncbi.nlm.nih.gov/pubmed/32793579
http://dx.doi.org/10.3389/fbioe.2020.00851
work_keys_str_mv AT williamsbianca predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT lobelwiebke predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT finkleaferdous predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT halloincaroline predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT ritzenhoffkatharina predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT mansteinfelix predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT mohammadisamira predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT hashemimohammadjafar predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT zweigerdtrobert predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT lipkeelizabeth predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling
AT cremaschiselen predictionofhumaninducedpluripotentstemcellcardiacdifferentiationoutcomebymultifactorialprocessmodeling